Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brandi N Reeves

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|December 4, 2018
A comparison of response in the presence or absence of a delay in induction therapy with bortezomib, lenalidomide, and dexamethasoneAllison J Schepers, Alexis R Jones, Brandi N Reeves, et al.
Blood Advances|November 5, 2025
Hypoxia-inducible Factors Contribute to Venous Thrombosis in a Mouse Model of Myeloproliferative NeoplasmsShatadal Ghosh, Joanna Miklosz, Fatima Trebak, et al.
Blood Advances|March 24, 2020
Thrombotic, inflammatory, and HIF-regulated genes and thrombosis risk in polycythemia vera and essential thrombocythemiaRadhika Gangaraju, Jihyun Song, Soo Jin Kim, et al.
Haematologica|November 27, 2025
Metformin alleviates side effects and supports the resumption of interferon therapy in polycythemia vera and essential thrombocythemiaBrandi N Reeves, Jihyun Song, André Leier, et al.
American Journal of Hematology|November 8, 2021
Tissue factor activity is increased in neutrophils from JAK2 V617F-mutated essential thrombocythemia and polycythemia vera patientsBrandi N Reeves, Soo Jin Kim, Jihyun Song, et al.
Annals of Hematology|July 10, 2025
A pharmacovigilance study of adverse events associated with polycythemia vera treatments using the FDA Adverse Event Reporting System (FAERS) databaseBrandi N Reeves, Lucia Masarova, Ghaith Abu-Zeinah, et al.
Blood Advances|January 26, 2026
Ropeginterferon alfa-2b has minimal transplacental passage and breastmilk secretion in pregnant MPN patientsTsewang Tashi, Lee-Yung Shih, Yi-Te Yo, et al.
Blood|June 6, 2022
Prophylactic tranexamic acid in patients with hematologic malignancy: a placebo-controlled, randomized clinical trialTerry B Gernsheimer, Siobhan P Brown, Darrell J Triulzi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 9, 2011
Natural history of paclitaxel-associated acute pain syndrome: prospective cohort study NCCTG N08C1Charles L Loprinzi, Brandi N Reeves, Shaker R Dakhil, et al.
Cancer|March 15, 2012
Further data supporting that paclitaxel-associated acute pain syndrome is associated with development of peripheral neuropathy: North Central Cancer Treatment Group trial N08C1Brandi N Reeves, Shaker R Dakhil, Jeff A Sloan, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|December 4, 2018
A comparison of response in the presence or absence of a delay in induction therapy with bortezomib, lenalidomide, and dexamethasoneAllison J Schepers, Alexis R Jones, Brandi N Reeves, et al.
Blood Advances|November 5, 2025
Hypoxia-inducible Factors Contribute to Venous Thrombosis in a Mouse Model of Myeloproliferative NeoplasmsShatadal Ghosh, Joanna Miklosz, Fatima Trebak, et al.
Blood Advances|March 24, 2020
Thrombotic, inflammatory, and HIF-regulated genes and thrombosis risk in polycythemia vera and essential thrombocythemiaRadhika Gangaraju, Jihyun Song, Soo Jin Kim, et al.
Haematologica|November 27, 2025
Metformin alleviates side effects and supports the resumption of interferon therapy in polycythemia vera and essential thrombocythemiaBrandi N Reeves, Jihyun Song, André Leier, et al.
American Journal of Hematology|November 8, 2021
Tissue factor activity is increased in neutrophils from JAK2 V617F-mutated essential thrombocythemia and polycythemia vera patientsBrandi N Reeves, Soo Jin Kim, Jihyun Song, et al.
Annals of Hematology|July 10, 2025
A pharmacovigilance study of adverse events associated with polycythemia vera treatments using the FDA Adverse Event Reporting System (FAERS) databaseBrandi N Reeves, Lucia Masarova, Ghaith Abu-Zeinah, et al.
Blood Advances|January 26, 2026
Ropeginterferon alfa-2b has minimal transplacental passage and breastmilk secretion in pregnant MPN patientsTsewang Tashi, Lee-Yung Shih, Yi-Te Yo, et al.
Blood|June 6, 2022
Prophylactic tranexamic acid in patients with hematologic malignancy: a placebo-controlled, randomized clinical trialTerry B Gernsheimer, Siobhan P Brown, Darrell J Triulzi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 9, 2011
Natural history of paclitaxel-associated acute pain syndrome: prospective cohort study NCCTG N08C1Charles L Loprinzi, Brandi N Reeves, Shaker R Dakhil, et al.
Cancer|March 15, 2012
Further data supporting that paclitaxel-associated acute pain syndrome is associated with development of peripheral neuropathy: North Central Cancer Treatment Group trial N08C1Brandi N Reeves, Shaker R Dakhil, Jeff A Sloan, et al.
Pageof 3